Masterflex SE (ISIN: DE0005492938) announced preliminary results for the 2025 financial year, confirming it has met its forecast and achieved new record earnings. The company reported consolidated revenue of EUR 102.6 million, a 4.6% increase from EUR 98.1 million in the previous year, within the guided range of EUR 100 million to EUR 105 million. Despite a challenging economic environment, particularly in Germany, operational performance remained robust, with the US subgroup and medical technology sector showing notable strength.
Operating EBITDA rose by 7.4% to EUR 19.5 million, up from EUR 18.2 million, while operating EBIT increased by 9.8% to EUR 13.97 million, surpassing the prior year's EUR 12.7 million. EBIT reached EUR 13.7 million, a 9.2% improvement from EUR 12.5 million, and within the forecast of EUR 12 million to EUR 15 million. The operating EBIT margin improved to 13.6% from 13.0%, reflecting sustained earnings strength despite currency losses and start-up costs for a new site in Morocco.
A key driver of growth was the medical technology segment, which saw its share of consolidated revenue rise from 18% in 2024 to 21% in 2025, driven by dynamic demand growth. The order backlog remained stable at EUR 19.8 million, consistent with the previous year. The company also strengthened its financial position, with the equity ratio improving to 73.3% from 67.7% and net debt falling to EUR 2.7 million from EUR 9.0 million. The debt ratio (net debt/EBITDA) improved to 0.1 from 0.5.
Dr. Andreas Bastin, CEO of Masterflex SE, commented: “Despite a continuing challenging economic environment, we met our forecasts in the 2025 financial year, achieved solid revenue growth and slightly increased our profitability thanks to continuous efficiency improvements. The development of our medical technology business and the further strengthening of our balance sheet are particularly pleasing. Building on this solid foundation, we are in a good position to continue our usual growth course in the coming years.”
The preliminary figures are subject to confirmation by auditors and approval by the Supervisory Board. The full 2025 consolidated financial statements and the 2026 forecast will be published on 31 March 2026. For more details, refer to the original release at NewMediaWire.
